◼ Archived
Business
🔮 fades ✗
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
GLP-1 weight loss drugs are being used by a record number of Americans.
Glp-1 Drugs
8 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✗
Amid heat wave, doctors warn of health risks for people taking GLP-1 drugs
Medical professionals are warning that GLP-1 drugs and other common medications can increase health risks during current heat waves.
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Researchers and doctors are exploring the broader implications of GLP-1 weight loss drugs as their use becomes more widespread.
◼ Archived
Business
🔮 fades ✓
Seniors in Medicare are about to get landmark obesity drug coverage
Starting July 1, 2026, Medicare will cover GLP-1 weight-loss drugs for seniors, marking a significant expansion in obesity treatment access.
◼ Archived
Business
🔮 fades ✓
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage
Employers are reconsidering coverage for popular GLP-1 weight loss drugs, leaving patients and insurers in limbo.
◼ Archived
Health
🔮 holds ✗
GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
New research indicates that GLP-1 receptor agonists, including Ozempic, are being misused by individuals with eating disorders.
◼ Archived
Health
🔮 fades ✓
Strange Side Effect Found Among Ozempic Users—and It Has to Do With Smell and Taste
Ozempic users report unexpected changes in their sense of smell and taste.
◼ Archived
Health
🔮 fades ✓
Medicare launches pilot program expanding access to GLP-1 drugs
Medicare's new pilot program expands access to GLP-1 drugs, sparking coverage on eligibility and potential impacts.